Focus: Avive Solutions is a Brisbane-based biotechnology company specializing in Automated External Defibrillator (AED) technology with a focus on gene therapy applications. The company operates as a small-scale biotech player with limited public visibility.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Growing — net +12 jobs in 30d
15 jobs added vs 3 removed. Steady team buildout.
Avive Solutions presents a high-risk, high-potential-upside opportunity best suited for early-stage biotech professionals comfortable with uncertainty in exchange for equity-upside and operational influence.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Avive Solutions
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Avive Solutions's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles